Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes (Q29398493)
Jump to navigation
Jump to search
scientific article (publication date: 25 October 2007)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes |
scientific article (publication date: 25 October 2007) |
Statements
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes (English)
1 reference
J. Cortes
1 reference
G. Garcia-Manero
1 reference
H. Yang
1 reference
C. Bueso-Ramos
1 reference
A. Ferrajoli
1 reference
W. G. Wierda
1 reference
S. Faderl
1 reference
C. Koller
1 reference
G. Morris
1 reference
G. Rosner
1 reference
A. Loboda
1 reference
V. R. Fantin
1 reference
S. S. Randolph
1 reference
J. S. Hardwick
1 reference
J. F. Reilly
1 reference
C. Chen
1 reference
J. L. Ricker
1 reference
J. P. Secrist
1 reference
V. M. Richon
1 reference
S. R. Frankel
1 reference
H. M. Kantarjian
1 reference
25 October 2007
1 reference
1 reference
111
1 reference
3
1 reference
1060-1066
1 reference